In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
News stories about efforts to eliminate and prevent cancer often tell the story in broad strokes, painting an almost...
If you toasted 2023 with champagne, then woke up pledging a month of sobriety, you’re not alone. In the...
Guest post by Hisham Hamadeh, PhD, and Shawn M. Sweeney, PhD Imagine a world where many of the decisions...
2023 is upon us, but before we dive into the new year, let’s look back at the featured articles...
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
Amy Bianchi discovered a lump in her breast when her first child was 18 months old. She was diagnosed...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...
This year, the American Association for Cancer Research (AACR) launched a series of Patient Advocate Forums, virtual conversations featuring...
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but...